The Ozempic Era Grows Up

What the Latest NEJM Review Gets Right, and Glosses Over A Critique and Summary of the GLP-1 Receptor Agonists Review by Clifford J. Rosen and Julie R. Ingelfinger, published in NEJM ON April 2, 2026. The New England Journal of Medicine just published a sweeping review of GLP-1 receptor agonists, the class of drugs behindContinueContinue reading “The Ozempic Era Grows Up”